Rapid HTAs of six medical devices released in Tuscany in November 2025

The Tuscany Regional Healthcare HTA body issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With the regional decrees 23574 of November 10, 2025, and 24034 of November 17, 2025, Tuscany Regional Healthcare published six rapid HTA reports (five new assessments and one reassessment) of medical devices in the cardiovascular, gastroenterology, ophthalmology, dermatology (dressing) and surgical (consumables) fields.

Some examples of evaluated technologies are provided below:

• Archimedes BPS (by AMG International GmbH), a biodegradable biliary and pancreatic stent for patients undergoing complex abdominal surgery, particularly robotic and open duodenopancreatectomies;
• Implantable artificial iris (ARTIFICIALIRIS SELECT by Human Optics) for patients with total or partial aniridia, whether congenital or acquired, with or without associated ocular conditions (aphakia, pseudophakia), who require functional and aesthetic iris correction.

See the regional decrees and all assessments in Italian and English here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.